Immunotherapy in Kidney Cancer
0 意见
• 06/26/23
0
0
嵌入
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论